Highlights GI Dynamics, Inc.

Equities

GIDYL

AU000000GID7

Delayed OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-99.33%

2023	GI Dynamics, Inc. Announces First Patient Enrolled in the I-STEP Clinical Study of EndoBarrier in India	CI
2022	GI Dynamics, Inc. Announces Final Data from the ENDO Trial, Multicenter Study Demonstrating the Potential Use of EndoBarrier to Treat Type II Diabetes and Obesity	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GI Dynamics, Inc. Announces First Patient Enrolled in the I-STEP Clinical Study of EndoBarrier in India	23-02-13	CI
GI Dynamics, Inc. Announces Final Data from the ENDO Trial, Multicenter Study Demonstrating the Potential Use of EndoBarrier to Treat Type II Diabetes and Obesity	22-06-15	CI
GI Dynamics Inc. Announces Approval of the I-STEP Clinical Study in India	22-01-31	CI
Gi Dynamics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-07	CI
Gi Dynamics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-12	CI
Gi Dynamics, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-10	CI
Gi Dynamics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-07	CI
Gi Dynamics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-06	CI
Gi Dynamics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-02-27	CI
GI Dynamics Inc Announces the First Patient in the United States Step-1 Clinical Trial Has Been Enrolled at Michigan Medicine in Ann Arbor, Michigan	20-01-27	CI
Gi Dynamics® Inc. Announces Positive EndoBarrier Data from University of Freiburg in Germany Showing Improvements of Cardiovascular Risk (CV) Biomarkers and Predicted 4-Year Risk of Major CV Events	20-01-14	CI
Gi Dynamics, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-08	CI
GI Dynamics, Inc. Presents Worldwide Endobarrier Registry Data for 871 Patients at EASD 2019	19-09-19	CI
Gi Dynamics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-15	CI
GI Dynamics Inc. Announces the Execution of its Contract with Surgical Specialists of Louisiana	19-07-30	CI
GI Dynamics Announces Lead Clinical Study Site for US Pivotal Trial of EndoBarrier	19-07-10	CI
GI Dynamics, Inc. Announces Enrolling Patients with Type 2 Diabetes and Obesity During the Second Half of 2019	19-06-12	CI
Gi Dynamics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-16	CI
GI Dynamics, Inc. Announces Positive Results on One-Year Data from the Association of British Clinical Diabetologists Endobarrier Obstructive Sleep Apnea Study	19-03-28	CI
GI Dynamics Inc. Announces Positive Results on Final Data from the United Kingdom's National Health Service Endobarrier Service	19-03-14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights GI Dynamics, Inc.

Equities

GIDYL

AU000000GID7

Highlights

Filters